Cargando…
Efficacy of a Novel Antibacterial Agent Exeporfinium Chloride, (XF-73), Against Antibiotic-Resistant Bacteria in Mouse Superficial Skin Infection Models
BACKGROUND: The number of incidences of antimicrobial resistance is rising continually, necessitating new and effective antibacterial drugs. The present study aimed to assess the in vitro and in vivo activity of XF-73 against antibiotic-resistant Staphylococcus aureus (S. aureus) isolates and to inv...
Autores principales: | Zhang, Chenrui, Li, Jinping, Lu, Rong, Wang, Song, Fu, Zheng, Yao, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386860/ https://www.ncbi.nlm.nih.gov/pubmed/37520450 http://dx.doi.org/10.2147/IDR.S417231 |
Ejemplares similares
-
Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study
por: Mangino, Julie E., et al.
Publicado: (2023) -
Antibacterial and Antibiofilm Potency of XF Drugs, Impact of Photodynamic Activation and Synergy With Antibiotics
por: Board-Davies, Emma Louise, et al.
Publicado: (2022) -
Screening of the novel antimicrobial drug, XF-73, against 2,527 Staphylococcus species clinical isolates
por: Rhys-Williams, William, et al.
Publicado: (2023) -
Extracting the strange density from xF$_{3}$
por: Barone, V, et al.
Publicado: (1995) -
Calculation of ATP production rates using the Seahorse XF Analyzer
por: Desousa, Brandon R, et al.
Publicado: (2023)